We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$309M
AUM Growth
+$4.26M
Cap. Flow
-$4.95M
Cap. Flow %
-1.6%
Top 10 Hldgs %
35.62%
Holding
365
New
19
Increased
44
Reduced
54
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
201
Texas Instruments
TXN
$236B
$31K 0.01%
350
UNH icon
202
UnitedHealth
UNH
$353B
$29K 0.01%
150
DOC icon
203
Healthpeak Properties
DOC
$14.5B
$27K 0.01%
966
KMX icon
204
CarMax
KMX
$8.81B
$27K 0.01%
350
-100
-22% -$6.67K
BMS
205
DELISTED
Bemis
BMS
$27K 0.01%
600
HSEB.CL
206
DELISTED
HSBC Holdings plc
HSEB.CL
$27K 0.01%
1,000
LLY icon
207
Eli Lilly
LLY
$1.05T
$26K 0.01%
300
NSC icon
208
Norfolk Southern
NSC
$78.3B
$26K 0.01%
200
SDY icon
209
State Street SPDR S&P Dividend ETF
SDY
$22B
$26K 0.01%
280
BIDU icon
210
Baidu
BIDU
$32.9B
$25K 0.01%
100
PNC icon
211
PNC Financial Services
PNC
$96.6B
$25K 0.01%
188
SJM icon
212
J.M. Smucker
SJM
$14.1B
$25K 0.01%
238
MCHP icon
213
Microchip Technology
MCHP
$39.6B
$24K 0.01%
538
SWBI icon
214
Smith & Wesson
SWBI
$573M
$24K 0.01%
2,082
COST icon
215
Costco
COST
$419B
$23K 0.01%
140
UNP icon
216
Union Pacific
UNP
$183B
$23K 0.01%
200
WMT icon
217
Walmart Inc
WMT
$820B
$23K 0.01%
900
CC icon
218
Chemours
CC
$2.35B
$22K 0.01%
436
GSK icon
219
GSK
GSK
$102B
$22K 0.01%
440
MPC icon
220
Marathon Petroleum
MPC
$104B
$22K 0.01%
400
TXT icon
221
Textron
TXT
$14.3B
$22K 0.01%
400
CMD
222
DELISTED
Cantel Medical Corporation
CMD
$22K 0.01%
230
CALM icon
223
Cal-Maine
CALM
$3.75B
$21K 0.01%
500
KLAC icon
224
KLA
KLAC
$229B
$21K 0.01%
2,000
NQP
225
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$21K 0.01%
+1,558
New +$21.2K

Similar funds

American Research & Management Company's Q3 2017 Portfolio in Review

As of Q3 2017, American Research & Management Company held 365 positions worth $309M, up 1.4% from $304M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

American Research & Management Company's Q3 2017 filing shows 19 new, 44 increased, 54 reduced and 13 closed positions. Its largest new stake was Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu: 40,000 shares worth $1.03M. The largest sale was PrivateBancorp, Inc. Capital Trust IV Trust Preferred, an estimated $5.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.

  • American Research & Management Company's largest Q3 2017 buy was Wells Fargo & Company Depositary Shares, each representing a 1/1,000th interest in a share of Non-Cu: 40,000 shares worth $1.03M.
  • American Research & Management Company added most to DuPont de Nemours in Q3 2017, an estimated $2.88M increase.
  • American Research & Management Company's biggest Q3 2017 reduction was State Street SPDR ICE Preferred Securities ETF, cutting an estimated $5.34M.
  • American Research & Management Company fully exited PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q3 2017, selling an estimated $5.7M.
  • American Research & Management Company's ten largest holdings make up 36% of its $309M portfolio in Q3 2017.
  • American Research & Management Company opened 19 new positions and closed 13 in Q3 2017.
  • American Research & Management Company's portfolio value rose 1.4% quarter-over-quarter to $309M.

Based on American Research & Management Company's 13F filing for Q3 2017, filed 17 Oct 2017.